A peer-reviewed journal published by K. N. Toosi University of Technology

Investigation of neutron dose and secondary cancer risk in pelvic and brain radiotherapy with a high-energy LINAC

Document Type : Research Article

Author

Sahand University of Technology, Tabriz, Iran

Abstract
‎This work aimed to assess the secondary cancer risk for patients undergoing brain and pelvic radiotherapy with high-energy linear accelerators (LINAC)‎. ‎Photoneutrons are produced in the LINAC's head when operating above 7 MeV and are not considered in radiotherapy treatment planning‎. ‎The MCNPX2.6 Monte Carlo code was used for LINAC's head simulation‎. ‎The photon and neutron doses were calculated in tissues/organs of an International Commission on Radiological Protection (ICRP) male reference voxel phantom undergoing pelvic and brain radiotherapy‎. The results indicated that the neutron equivalent dose was higher for tissues/organs located close to skin and‎, ‎contrary to the photon equivalent dose‎, ‎did not decrease sharply for tissues/organs outside of the irradiation field‎. ‎Notably‎, ‎neutron equivalent dose distribution was almost homogenous in whole body and did not depend on the treatment type and location of target organ‎. ‎Therefore‎, ‎an undesirable dose was received by healthy tissues/organs‎, ‎leading to an increase in secondary cancer risk‎. ‎Based on the obtained results‎, ‎the neutron effective dose for the pelvic and brain treatment were 0.20 and 0.26 mSv.Gy-1‎, ‎respectively‎. ‎The results also indicated that maximum secondary cancer risk due to neutrons was for colon (0.026 %) in the pelvic treatment‎, ‎while in brain treatment‎, ‎it belongs to stomach (0.036 %) for a delivered dose of 70 Gy‎. ‎It is recommended that a mean neutron effective dose value of 0.23 mSv.Gy-1 can be considered in brain and pelvic treatment planning for evaluating the secondary cancer risk of high-energy LINAC radiotherapy‎.

Highlights

  • The secondary cancer risk for patients undergoing brain and pelvic radiotherapy with high-energy LINAC.
  • The MCNPX2.6 code was used for the 15 MV Primus Siemens LINAC’s head simulation and dose calculations.
  • The neutron equivalent dose was greater for tissues/organs located near the skin compared to that of photon.
  • The neutron effective dose for the pelvic and brain treatment were 0.20 and 0.26 mSv.Gy−1, respectively.
  • The neutron equivalent dose distribution was unfluctuating in the whole body and independent of the type of treatment.

Keywords


Alem-Bezoubiri, A., Bezoubiri, F., Badreddine, A., et al. (2014). Monte Carlo estimation of photoneutrons spectra and dose equivalent around an 18 MV medical linear accelerator. Radiation Physics and Chemistry, 97:381–392.
Barquero, R., Edwards, T., Iniguez, M., et al. (2005). Monte Carlo simulation estimates of neutron doses to critical organs of a patient undergoing x-ray LINAC-based radiotherapy. Medical Physics, 32(12):3579–3588.
Bezak, E., Takam, R., Yeoh, E., et al. (2017). The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy. Physica Medica, 42:253–258.
Chegeni, N., Karimi, A. H., Jabbari, I., et al. (2018). Photoneutron dose estimation in GRID therapy using an anthropomorphic phantom: A Monte Carlo study. Journal of Medical Signals & Sensors, 8(3):175–183.
Chibani, O. and Ma, C.-M. C. (2003). Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs. Medical Physics, 30(8):1990–2000.
Ghiasi, H. and Mesbahi, A. (2010). Monte Carlo characterization of photoneutrons in the radiation therapy with high energy photons: a Comparison between simplified and full Monte Carlo models.
Howell, R. M., Hertel, N. E., Wang, Z., et al. (2006). Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for, and beam energies. Medical Physics, 33(2):360–368.
Hsu, F.-Y., Chang, Y.-L., Liu, M.-T., et al. (2010). Dose estimation of the neutrons induced by the high energy medical linear accelerator using dual-TLD chips. Radiation Measurements, 45(3-6):739–741.
ICRP (2007). ICRP publication 103. Ann ICRP, 37(2.4):2.
ICRP (2009). Adult reference computational phantoms. ICRP Publication 110. Ann. ICRP, 39(2):1.
Kry, S. F., Howell, R. M., Salehpour, M., et al. (2009). Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy. Medical Physics, 36(4):1244–1250.
Martinez-Ovalle, S., Barquero, R., Gomez-Ros, J., et al. (2011). Neutron dose equivalent and neutron spectra in tissue for clinical linacs operating at 15, 18 and 20 MV. Radiation Protection Dosimetry, 147(4):498–511.
Mohammadi, N., Hakimabad, H. M., and Motavalli, L. R. (2015a). Neural network unfolding of neutron spectrum measured by gold foil-based Bonner sphere. Journal of Radioanalytical and Nuclear Chemistry, 303:1687–1693.
Mohammadi, N., Miri-Hakimabad, H., Rafat-Motavlli, L., et al. (2015b). Neutron spectrometry and determination of neutron contamination around the 15 MV Siemens Primus LINAC. Journal of Radioanalytical and Nuclear Chemistry, 304:1001–1008.
Mohammadi, N., Miri-Hakimabad, S. H., and Rafat-Motavalli, L. (2014). A Monte Carlo study for photoneutron dose estimations around the high-energy linacs. Journal of Biomedical Physics & Engineering, 4(4):127.
Mukherjee, B., Makowski, D., and Simrock, S. (2005). Dosimetry of high-energy electron linac produced photoneutrons and the bremsstrahlung gamma-rays using TLD-500 and TLD-700 dosimeter pairs. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 545(3):830–841.
NCRP (1993). NCRP Report National Committee on Radiation Protection and Measurements (US). National Council on Radiation Protection and Measurements.
Ongaro, C., Zanini, A., Nastasi, U., et al. (2000). Analysis of photoneutron spectra produced in medical accelerators. Physics in Medicine & Biology, 45(12):L55.
Pelowitz, D. et al. (2005). Los Alamos National Laboratory report. Technical report, LA-CP-05-0369.
Rajesh, K., Raman, R. G., Musthafa, M., et al. (2020). A passive method for absolute dose evaluation of photoneutrons in radiotherapy. International Journal of Radiation Research, 18(1):173–178.
Sánchez-Doblado, F., Domingo, C., Gómez, F., et al. (2012). Estimation of neutron-equivalent dose in organs of patients undergoing radiotherapy by the use of a novel online digital detector. Physics in Medicine & Biology, 57(19):6167.
Sánchez-Nieto, B., Romero-Expósito, M., Terrón, J. A., et al. (2017). Uncomplicated and Cancer-Free Control Probability (UCFCP): a new integral approach to treatment plan optimization in photon radiation therapy. Physica Medica, 42:277–284.
Stathakis, S., Li, J., and Ma, C. C. (2007). Monte Carlo determination of radiation-induced cancer risks for prostate patients undergoing intensity-modulated radiation therapy. Journal of Applied Clinical Medical Physics, 8(4):14–27.
Thalhofer, J., Roque, H., Rebello, W., et al. (2014). Effect of external shielding for neutrons during radiotherapy for prostate cancer, considering the 2300 CD linear accelerator and voxel phantom. Radiation Physics and Chemistry, 95:267–270.
Volume 6, Issue 1
Winter 2025
Pages 65-73

  • Receive Date 12 June 2024
  • Revise Date 13 September 2024
  • Accept Date 07 October 2024